Quarterly report · Q2
2533.TEDINET S100RII0
Period2023-01-01 → 2023-06-30
Filed2023-08-04
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥42.7bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥81.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥38.4bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥2.0bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥147m | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥645m | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥77m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥182m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.7bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥744m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.7bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥821m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥51.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥55.5bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥50.3bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.5bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥35.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.4bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.0bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥621m | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥899m | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥616m | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥894m | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥839m | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥986m | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥94m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥860m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥532m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥716m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.4bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.52 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.81 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.22 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-12.53 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.1 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 37.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-06-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-06-30 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-06-30 | ¥2m |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥13m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥13m |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.8bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥360m |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥38.8bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥38.8bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥13m |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥662m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥662m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥352m |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥6m |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥42.6bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥42.6bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥13m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥2.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥37m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥37m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | ¥7m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q2r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥338m |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥34.2bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥34.2bn |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥446m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥190m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥190m |
| jpcrp040300-q2r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥102m |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q2r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥149m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥38.3bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥38.3bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | −¥154m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 593
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)石 田 大 輔 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 宮 正 俊 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 38368000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 42657000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 81120000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -77000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 2101000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -645000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -744000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1718000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -1257000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -607000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 2093000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -1653000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 21000000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 20422000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 19604000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 50269000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 51903000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 55511000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -12.53 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 29.52 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -21.22 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | - | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | - | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | - | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.379 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.377 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.320 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | -2628000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -94000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -860000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -1922000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | 532000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -4040000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 4405000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -716000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 4809000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 839000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 616000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 894000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | -10.10 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 15.81 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 65586196 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 65586196 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 65586196 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 65586196 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |